Stephen Mayo - Aug 7, 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/Lillian Smith, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Aug 7, 2023
Transactions value $
-$42,855
Form type
4
Date filed
8/9/2023, 04:07 PM
Previous filing
Jun 15, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale -$42.9K -10K -28.31% $4.29 25.3K Aug 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.27 to $4.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.